A multicentre, multinational, double-blind, randomized, active-controlled, parallel-group clinical study to assess the safety and efficacy of PDA10 (Epoetin-alfa) vs. Eprex in patients with anemia of chronic renal failure - Lim, S K; Goh, B L; Visvanathan, R (BMC Nephrology, 2021)
et.al.